Clinical evaluation of direct acting antiviral agents intended for treatment of chronic hepatitis C

  • Email
  • Help
Current effective version

Adopted guideline

Currently under revision - see below

Reference numberCHMP/EWP/30039/2008
Published23/04/2009
Effective from01/11/2009
KeywordsHepatitis C, chronic hepatitis C (CHC), direct antivirals, interferon, ribavirin, transplantation, standard of care (SOC), hepatitis C virus (HCV) RNA
DescriptionThis document provides guidance on the clinical development of compounds for the treatment of chronic hepatitis C. It focuses on direct-acting anti-viral agents.


Document history

Revision 1

In progress

Draft guideline (second version)

 

Draft guideline


Concept paper

Published: 07/07/2016

 

Published: 14/02/2011


Published: 30/04/2010

First version

Current version

Adopted guideline


Overview of comments


Draft guideline


Concept paper

In operation: 01/11/2009–present


Published: 23/04/2009


Published: 24/04/2008


Published: 26/04/2007


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more